Calabrò L - Search Results

1

CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.

Kalbasi A, Fonsatti E, Natali PG, Altomonte M, Bertocci E, Cutaia O, Calabrò L, Chiou M, Tap W, Chmielowski B, Maio M, Ribas A. Kalbasi A, et al. Among authors: calabro l. J Immunother. 2010 Oct;33(8):810-6. doi: 10.1097/CJI.0b013e3181ee73a7. J Immunother. 2010. PMID: 20842056

2

Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies.

Maio M, Altomonte M, Calabro L, Fonsatti E. Maio M, et al. Among authors: calabro l. Front Biosci. 2001 Jun 1;6:D776-84. doi: 10.2741/maio. Front Biosci. 2001. PMID: 11401781 Review.

3

Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.

De Nardo C, Fonsatti E, Sigalotti L, Calabrò L, Colizzi F, Cortini E, Coral S, Altomonte M, Maio M. De Nardo C, et al. Among authors: calabro l. J Cell Physiol. 2002 Feb;190(2):200-6. doi: 10.1002/jcp.10050. J Cell Physiol. 2002. PMID: 11807824

4

Differential levels of soluble endoglin (CD105) in myeloid malignancies.

Calabrò L, Fonsatti E, Bellomo G, Alonci A, Colizzi F, Sigalotti L, Altomonte M, Musolino C, Maio M. Calabrò L, et al. J Cell Physiol. 2003 Feb;194(2):171-5. doi: 10.1002/jcp.10200. J Cell Physiol. 2003. PMID: 12494455

5

Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.

Altomonte M, Visintin A, Tecce R, Leonardi A, Calabro L, Fonsatti E, Pucillo C, Maio M. Altomonte M, et al. Among authors: calabro l. J Cell Physiol. 2004 Aug;200(2):272-6. doi: 10.1002/jcp.20015. J Cell Physiol. 2004. PMID: 15174097

6

Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.

Calabrò L, Fonsatti E, Altomonte M, Pezzani L, Colizzi F, Nanni P, Gattei V, Sigalotti L, Maio M. Calabrò L, et al. J Cell Physiol. 2005 Feb;202(2):474-7. doi: 10.1002/jcp.20133. J Cell Physiol. 2005. PMID: 15389591

7

Epigenetic immunomodulation of hematopoietic malignancies.

Gattei V, Fonsatti E, Sigalotti L, Degan M, Di Giacomo AM, Altomonte M, Calabrò L, Maio M. Gattei V, et al. Among authors: calabro l. Semin Oncol. 2005 Oct;32(5):503-10. doi: 10.1053/j.seminoncol.2005.07.006. Semin Oncol. 2005. PMID: 16210091 Review.

8

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M. Sigalotti L, et al. Among authors: calabro l. J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review.

9

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

Fonsatti E, Nicolay HJ, Sigalotti L, Calabrò L, Pezzani L, Colizzi F, Altomonte M, Guidoboni M, Marincola FM, Maio M. Fonsatti E, et al. Among authors: calabro l. Clin Cancer Res. 2007 Jun 1;13(11):3333-8. doi: 10.1158/1078-0432.CCR-06-3091. Clin Cancer Res. 2007. PMID: 17545540

10

Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?

Calabrò L, Di Giacomo AM, Altomonte M, Fonsatti E, Mazzei MA, Volterrani L, Miracco C, Maio M. Calabrò L, et al. J Exp Clin Cancer Res. 2007 Mar;26(1):145-50. J Exp Clin Cancer Res. 2007. PMID: 17550144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters